Woodford Investment Management Ltd - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 110 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2019. The put-call ratio across all filers is 2.28 and the average weighting 0.7%.

Quarter-by-quarter ownership
Woodford Investment Management Ltd ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q3 2019$221,112,000
+11.4%
11,350,719
-6.7%
71.30%
+112.3%
Q2 2019$198,573,000
-34.5%
12,159,980
-9.1%
33.59%
+37.2%
Q1 2019$303,324,000
-3.8%
13,379,979
+8.6%
24.48%
-10.2%
Q4 2018$315,180,000
-17.5%
12,316,529
+5.3%
27.26%
-10.4%
Q3 2018$382,071,000
+50.2%
11,694,879
+4.3%
30.43%
-1.3%
Q2 2018$254,331,000
-3.8%
11,213,879
+2.9%
30.84%
+31.2%
Q1 2018$264,297,000
-11.8%
10,898,879
+1.4%
23.51%
+16.3%
Q4 2017$299,737,000
-18.2%
10,747,108
+0.4%
20.21%
+20.1%
Q3 2017$366,577,000
-14.1%
10,706,108
-0.0%
16.83%
+7.4%
Q2 2017$426,531,000
+8.3%
10,706,180
+0.0%
15.67%
-3.9%
Q1 2017$393,948,000
+17.6%
10,705,108
+1.9%
16.31%
+1.1%
Q4 2016$334,983,000
-1.7%
10,507,608
+11.7%
16.13%
+17.0%
Q3 2016$340,915,000
+72.0%
9,407,137
+7.7%
13.78%
+48.0%
Q2 2016$198,166,000
+54.5%
8,733,637
+28.0%
9.31%
+58.8%
Q1 2016$128,303,000
+54.7%
6,824,637
+34.8%
5.86%
+64.7%
Q4 2015$82,960,000
+1992.8%
5,061,637
+1303.3%
3.56%
+1454.1%
Q3 2015$3,964,000360,6850.23%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q4 2019
NameSharesValueWeighting ↓
Link Fund Solutions Ltd 5,251,349$135,459,00069.86%
Chescapmanager LLC 949,006$24,570,0003.61%
Baupost Group 9,309,168$241,014,0002.66%
Rock Springs Capital Management LP 655,200$16,963,0000.54%
Rubric Capital Management LP 173,400$4,489,0000.51%
Newtyn Management, LLC 173,300$4,487,0000.41%
NJ State Employees Deferred Compensation Plan 38,142$988,0000.17%
King Wealth Management Group 22,500$583,0000.15%
Virtus ETF Advisers LLC 29,216$756,0000.12%
JACOBS LEVY EQUITY MANAGEMENT, INC 452,615$11,718,0000.12%
View complete list of THERAVANCE BIOPHARMA INC shareholders